News

New drug could delay type 1 diabetes, need for insulin injections Two bereaved parents and 12 fellow members of a fringe Australian religious congregation accused of killing an 8-year-old girl by ...
The authors were a 51-member panel co-led by health psychologist Jane Speight, PhD, director of the Australian Center for Behavioral Research in Diabetes (ACBRD), Diabetes Victoria, Melbourne ...
Diabetes Australia has today launched a transformative new research strategy, marking a new era in the organisation's role in Australian diabetes ...
Between 2000 and 2021, the number of people living with diabetes in Australia increased almost threefold, from 460,000 to 1.3 million.
A new study by the Menzies-led DIABETES Across the LIFECOURSE: Northern Australia Partnership (the Partnership) has ...
Diabetes — Australia's fastest growing chronic condition — is estimated to cost the country more than $17.6 billion a year.
Professor Dianna Magliano, Head, Diabetes and Population Health, Monash University, and Baker Heart and Diabetes Institute, Melbourne, Australia E) [email protected] T) +61 (0)425 706 637 ...
A study by Australian researchers has found that the humble sea cucumber may contain key ingredients that delay the onset of type 2 diabetes and reduce the complications brought about by the disease.
ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039.
In recent news, Ozempic, a drug for type 2 diabetes, is now in short supply in Australia after TikTokers are claiming that it can help with weight loss. TikTokers Promote Ozempic for Weight Loss Use ...